HEALTH● LOWJul 9 · Jul 9, 2026, 9:30 PM
Bausch + Lomb abandons glaucoma drops after phase 2 failure
Seeking Alpha Tech
Bausch + Lomb has discontinued its glaucoma drops development project. This decision follows the failure of the drug during its phase 2 trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH12m agoIsrael's election too close to call. And, the Ebola outbreak reaches grim milestoneNPR NewsHEALTH22m agoEbola: Survivors can transmit virus through sex, but not sweat or saliva – WHOPremium TimesHEALTH41m agoNorah's dermatologist shares skin care do's and don'tsCBS NewsHEALTH41m agoDo's and Don'ts for Preventing and Reversing Skin DamageCBS News